Zydus Lifesciences Limited ZYDUSLIFE.NS Stock
Zydus Lifesciences Limited Price Chart
Zydus Lifesciences Limited ZYDUSLIFE.NS Financial and Trading Overview
| Zydus Lifesciences Limited stock price | 1044.75 INR |
| Previous Close | 549.15 INR |
| Open | 552.15 INR |
| Bid | 552.8 INR x N/A |
| Ask | 553.1 INR x N/A |
| Day's Range | 548.1 - 559.3 INR |
| 52 Week Range | 329.8 - 559.3 INR |
| Volume | 1.26M INR |
| Avg. Volume | 1.04M INR |
| Market Cap | 559.29B INR |
| Beta (5Y Monthly) | 0.361643 |
| PE Ratio (TTM) | 29.406597 |
| EPS (TTM) | 37.91 INR |
| Forward Dividend & Yield | 6 (1.12%) |
| Ex-Dividend Date | July 27, 2023 |
| 1y Target Est | N/A |
ZYDUSLIFE.NS Valuation Measures
| Enterprise Value | 558.36B INR |
| Trailing P/E | 29.406597 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.2446373 |
| Price/Book (mrq) | 3.1933398 |
| Enterprise Value/Revenue | 3.239 |
| Enterprise Value/EBITDA | 15.616 |
Trading Information
Zydus Lifesciences Limited Stock Price History
| Beta (5Y Monthly) | 0.361643 |
| 52-Week Change | 63.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 559.3 INR |
| 52 Week Low | 329.8 INR |
| 50-Day Moving Average | 513.3 INR |
| 200-Day Moving Average | 452.02 INR |
ZYDUSLIFE.NS Share Statistics
| Avg. Volume (3 month) | 1.04M INR |
| Avg. Daily Volume (10-Days) | 1.37M INR |
| Shares Outstanding | 1.01B |
| Float | 250.78M |
| Short Ratio | N/A |
| % Held by Insiders | 75.38% |
| % Held by Institutions | 13.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 6 |
| Trailing Annual Dividend Yield | 1.09% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1292 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 11.37% |
| Operating Margin (ttm) | 16.54% |
| Gross Margin | 63.39% |
| EBITDA Margin | 20.74% |
Management Effectiveness
| Return on Assets (ttm) | 6.65% |
| Return on Equity (ttm) | 10.82% |
Income Statement
| Revenue (ttm) | 172.37B INR |
| Revenue Per Share (ttm) | 169.71 INR |
| Quarterly Revenue Growth (yoy) | 31.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 35.75B INR |
| Net Income Avi to Common (ttm) | 19.65B INR |
| Diluted EPS (ttm) | 18.79 |
| Quarterly Earnings Growth (yoy) | -25.39% |
Balance Sheet
| Total Cash (mrq) | 14.2B INR |
| Total Cash Per Share (mrq) | 14.03 INR |
| Total Debt (mrq) | 11.95B INR |
| Total Debt/Equity (mrq) | 6.07 INR |
| Current Ratio (mrq) | 1.811 |
| Book Value Per Share (mrq) | 173.032 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 26.89B INR |
| Levered Free Cash Flow (ttm) | 14.45B INR |
Profile of Zydus Lifesciences Limited
| Country | India |
| State | N/A |
| City | Ahmedabad |
| Address | Zydus Corporate Park |
| ZIP | 382481 |
| Phone | 91 79 7180 0000 |
| Website | https://www.zyduslife.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.
Q&A For Zydus Lifesciences Limited Stock
What is a current ZYDUSLIFE.NS stock price?
Zydus Lifesciences Limited ZYDUSLIFE.NS stock price today per share is 1044.75 INR.
How to purchase Zydus Lifesciences Limited stock?
You can buy ZYDUSLIFE.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zydus Lifesciences Limited?
The stock symbol or ticker of Zydus Lifesciences Limited is ZYDUSLIFE.NS.
Which industry does the Zydus Lifesciences Limited company belong to?
The Zydus Lifesciences Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Zydus Lifesciences Limited have in circulation?
The max supply of Zydus Lifesciences Limited shares is 1.01B.
What is Zydus Lifesciences Limited Price to Earnings Ratio (PE Ratio)?
Zydus Lifesciences Limited PE Ratio is 27.55869100 now.
What was Zydus Lifesciences Limited earnings per share over the trailing 12 months (TTM)?
Zydus Lifesciences Limited EPS is 37.91 INR over the trailing 12 months.
Which sector does the Zydus Lifesciences Limited company belong to?
The Zydus Lifesciences Limited sector is Healthcare.